A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial

Journal:

Nature Medicine

Published:

2025-11-24

DOI:

10.1038/s41591-025-03995-y

Affiliations:

3

Authors:

28

Go to article

Institutions	Authors	Share
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)	19.000000 19.000000	0.68
St. Jude Children's Research Hospital (St. Jude), United States of America (USA)	8.000000	0.29
Fibrolamellar Cancer Foundation, United States of America (USA)	1.000000	0.04

Interested in Oncology and Carcinogenesis?